Elevation of regulatory T Cells in Adults with CF receiving Elexacaftor/Tezacaftor/Ivacaftor Therapy

被引：0
|
作者：
Westhoelter, D. [1 ]
Ubner, H. [1 ]
Raspe, J. [1 ]
Schmitz, M. [2 ,3 ]
Ngoc, Tran L. [1 ]
Strassburg, S. [1 ]
Welsner, M. [1 ]
Sutharsan, S. [1 ]
Taube, C. [1 ]
Reuter, S. [1 ]
机构：
[1] Univ Med Essen, Ruhrlandklin, Klin Pneumol, Essen, Germany
[2] Univ Med Essen, Ruhrlandklin, Essen, Germany
[3] Univ Med Essen, Expt Pneumol, Klin Pneumol, Ruhrlandklin,Klin Pneumol, Essen, Germany
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
10.1055/s-0043-1760882
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV 47
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] Incidence of transaminitis in adults with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor
    Wood, Marci
    Babowicz, Faith
    Kennedy, Amanda G.
    Antell, Martine
    Gilhooly, Elizabeth
    Tompkins, Bradley J.
    Reddy, Sheela S.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (03) : 920 - 924
  • [22] Weight a minute: Exploring the effect on weight and body composition after the initiation of elexacaftor/tezacaftor/ivacaftor in adults with CF
    Proud, David
    Duckers, Jamie
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (05) : 847 - 850
  • [23] Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis
    Royo, Rosa Nieto
    Barata, Diego Duran
    Barreto, Deisy Barrios
    Franquiz, Winnifer Briceno
    Carro, Luis Maiz
    MEDICINA CLINICA, 2023, 161 (08): : 338 - 341
  • [24] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR AND WORK: IMPROVED HEALTH AFFECTS EMPLOYMENT OPPORTUNITIES FOR PEOPLE WITH CF
    Sufian, B.
    Passamano, J. A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S271 - S271
  • [25] Long-term outcomes in people with CF lacking early spirometry response to elexacaftor/tezacaftor/ivacaftor therapy
    Hadhud, Mohamad
    Reiter, Joel
    Ben Meir, Elad
    Gileles-Hillel, Alex
    Sadras, Ido
    Kerem, Eitan
    Cohen-Cymberknoh, Malena
    Breuer, Oded
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [26] Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy
    Southern, Kevin W.
    Barben, Jurg
    Goldring, Stephen
    Kneen, Rachel
    Southward, Suzanne
    Rajeev, Yashasvi
    Davies, Jane C.
    Bush, Andrew
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 103 - 105
  • [27] EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON CHRONIC SINONASAL SYMPTOMS IN ADULTS WITH CYSTIC FIBROSIS
    DiMango, E.
    Overdevest, J.
    Keating, C.
    Francis, Fracasso S.
    Dansky, D.
    Gudis, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S213 - S213
  • [28] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [29] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [30] Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
    Kam, Charissa W.
    Mckinzie, Cameron J.
    Omecene, Nicole E.
    Peters, Stacy
    Pettit, Rebecca S.
    Poisson, Margaret O.
    Witte, Jennifer
    PEDIATRIC PULMONOLOGY, 2025, 60 (01)
12345